Skip to main content

Monjuvi Disease Interactions

There are 2 disease interactions with Monjuvi (tafasitamab).

Moderate

Tafasitamab (applies to Monjuvi) liver dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

The effect of moderate to severe hepatic impairment (total bilirubin greater than 1.5 times ULN and any aspartate aminotransferase), on tafasitamab pharmacokinetics is unknown.

References

  1. (2020) "Product Information. Monjuvi (tafasitamab)." Morphosys US
Moderate

Tafasitimab (applies to Monjuvi) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

The effect of severe renal impairment to end-stage renal disease (ClCr less than 30 mL/min) on tafasitamab pharmacokinetics is unknown.

References

  1. (2020) "Product Information. Monjuvi (tafasitamab)." Morphosys US

Monjuvi drug interactions

There are 305 drug interactions with Monjuvi (tafasitamab).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer